Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin effects on breast tissue in women undergoing reduction mammoplasty
ACTRN12610000219088Phase 4Terminated
- Sponsor
- Monash University
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in breast cancer (2 arms), sponsored by Monash University. Primary endpoints: Change in LKB1 expression and activity, AMPK phosphorylation and CRTC2 phosphorylation and translocation and 1 more. Started May 2011; status: terminated.
02
Drugs
metformin
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12610000219088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000219088.